CacheBy
Thermo Fisher Scientific Rituximab Recombinant Rabbit Monoclonal Antibody (194D7), Biotin, MonoRab
원본

Thermo Fisher Scientific Rituximab Recombinant Rabbit Monoclonal Antibody (194D7), Biotin, MonoRab

상품 한눈에 보기

Rituximab 항원을 인식하는 재조합 토끼 단클론 항체로 Biotin 결합형 제품입니다. ELISA 등 연구용으로 사용되며 인간 시료 반응성이 있습니다. Lyophilized 형태로 제공되며 Protein A로 정제되었습니다. 연구용으로만 사용 가능합니다.

카탈로그번호
A0194440
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 01. 오후 10:40
Thermo Fisher Scientific A0194440 Rituximab Recombinant Rabbit Monoclonal Antibody (194D7), Biotin, MonoRab 40 ug pk판매 단위 pk ·
재고 확인 필요
339,200원VAT 포함 373,120원

Thermo Fisher Scientific · Thermo Fisher Scientific Rituximab Recombinant Rabbit Monoclonal Antibody (194D7), Biotin, MonoRab

Thermo Fisher Scientific Rituximab Recombinant Rabbit Monoclonal Antibody (194D7), Biotin, MonoRab

Applications and Tested Dilution

  • Application: ELISA
  • Tested Dilution: 0.005–1 µg/mL

Product Specifications

항목 내용
Species Reactivity Human
Host / Isotype Rabbit / IgG
Expression System Mammalian cells
Class Recombinant Monoclonal
Type Antibody
Clone 194D7
Immunogen Rituximab
Conjugate Biotin
Form Lyophilized
Purification Protein A
Storage Buffer PBS, pH 7.4, with 1% BSA
Contains 0.02% sodium azide
Storage Conditions -20°C or -80°C if preferred
Shipping Conditions Ambient (domestic); Wet ice (international)

Additional Formats

Product Specific Information

Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.

Rituximab was approved for medical use in 1997 and is listed on the World Health Organization’s List of Essential Medicines. It is used to treat various autoimmune diseases and cancers, including non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, and myasthenia gravis. Rituximab is a chimeric monoclonal antibody against the protein CD20 found on B cells; binding to CD20 induces cell death.

Target Information

Rituximab (Rituxan) is a humanized monoclonal antibody approved by the U.S. FDA for treatment of autoimmune diseases and cancers such as non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, idiopathic thrombocytopenic purpura, and pemphigus vulgaris. It targets CD20 on B cells, leading to cell death.

Usage Note

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.